The Cancer Imaging (CI) Program is a transdisciplinary program that integrates imaging and engineering research with the study of cancer biology. The goals of this program are to build novel imaging ...

AI assistance is associated with a superior improvement in detecting clinically significant prostate cancer on MRI, a ...

The Interdisciplinary Genitourinary Cancer Forum 2025, held between June 19 – 21, 2025 held in St. Petersburg, Florida, United States, was host to the Prostate Cancer Session 7: Non-metastatic ...

SAR-Bombesin targets the gastrin-releasing peptide receptor (GRPR), a promising pan-cancer target expressed in a number of ...

A breakthrough in bladder cancer treatment at the University of California, Davis: multifunctional nanoparticles enhance ...

Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative positron emission tomography (PET) radiopharmaceuticals, today announced ...

Triple-negative breast cancer (TNBC) is one of the most aggressive and difficult-to-treat forms of breast cancer. Unlike ...

The Cancer Imaging Initiative has established a network of four centres and four research programmes to drive forward multidisciplinary cancer imaging research in the UK. The initiative is a ...

(UroToday.com) The Interdisciplinary Genitourinary Cancer Forum 2025, held in St. Petersburg, Florida, United States, was host to the Prostate Cancer Session 2: Local Treatments. Dr. Peter Carroll ...

Supplementary contrast imaging detected more breast cancers than automated whole-breast ultrasound in women with dense breasts. The invasive tumor size found by abbreviated MRI and contrast ...

has approved the prostate cancer imaging agent trofolastat (RoTecPSMA). The regulator’s decision makes trofolastat the first prostate-specific membrane antigen (PSMA)-targeting product approved ...